权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Neuronal Mechanisms of Copper Transport and Toxicity

铜转运和毒性的神经机制

基本信息

批准号：
10366543
负责人：
Victor Faundez
金额：
$ 39.07万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-01 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10366543
关键词：
3xTg-AD mouse Address Administrative Supplement Affect Alleles Alzheimer&apos s Disease Alzheimer&apos s disease model Alzheimer&apos s disease pathology Alzheimer&apos s disease risk Amyloid Animal Model Apolipoprotein E Astrocytes Automobile Driving Award Biochemical Brain Categories Cause of Death Cell Line Cell membrane Cells Cholesterol Cholesterol Homeostasis Cognition Copper Data Defect Dementia Disease Drosophila genus ENG gene Event Functional disorder Gene Expression Genes Genetic Genetic Risk Homeostasis Impairment Inner mitochondrial membrane Leukemic Cell Link Mammalian Cell Maps Measures Medical Genetics Membrane Messenger RNA Microglia Mitochondria Mitochondrial Proteins Modeling Molecular Chaperones Mus Mutant Strains Mice Mutation Nerve Degeneration Neurons Pathogenesis Pathogenicity Pathology Pathway interactions Predisposition Process Production Protein Precursors Proteins Research Respiratory Chain Rest Risk SPI1 gene Synapses Testing Toxic effect United States United States National Institutes of Health Up-Regulation Work amyloid peptide brain cell citrate carrier complex IV experimental study falls genetic risk factor genome-wide interest lipidomics loss of function mitochondrial dysfunction mitochondrial membrane mouse model mutant neuroblastoma cell novel response risk variant uptake

项目摘要

PROJECT SUMMARY Alzheimer’s disease (AD) is a debilitating form of dementia, and a leading cause of death in the United States. Dominant pathogenesis models postulate that initiating factor are either the aberrant processing of the Alzheimer’s precursor protein (APP), which leads to the accumulation of amyloid peptide toxic species in brain or the expression of an Alzheimer’s disease associated allele, APOE4. In these models, mitochondria respond to the toxicity of amyloid peptides or APOE4 rather than mitochondria driving pathogenesis. Here we explore a novel mitochondrial mechanism initiated by genetic defects in copper delivery mechanisms to the mitochondria (ATP7A, SLC31A1, COX17), the inner mitochondrial membrane mitochondrial citrate transporter SLC25A1 and its interacting protein, NDUFS3. The latter a gene associated to a genetic risk loci in Alzheimer’s disease. We found that the main defect downstream of mutations in these genes that end affecting mitochondria is an upregulation of cholesterol synthesis pathways, cholesterol, and the expression of APOE. These findings have profound implications as they suggest that upregulation of cholesterol and APOE, key risks factor for Alzheimer’s disease, are initiated by a genetic defect affecting mitochondria. Our model challenges the current canonical view that mitochondrial dysfunction is a terminal link in a chain of events ending in synapse dysfunction and Alzheimer’s disease. We envision our mitochondria-driven pathogenesis model as a powerful addition rather than a replacement of the current paradigm of amyloid peptide- or APOE4-driven Alzheimer’s pathogenesis. We posit that the mitochondrion acting as initiator of pathology is an important concept because it argues that disease would unravel in a positive feed-forward circle integrating amyloid peptides, APOE4, cholesterol, and mitochondria. We will test this hypothesis with mouse mutants that impair copper delivery to mitochondria and stablished animal models of Alzheimer’s disease with clinical and genetic validity.

项目总结阿尔茨海默病(AD)是一种使人衰弱的痴呆症，也是美国主要的死亡原因。显性致病模型假设，启动因素要么是阿尔茨海默病前体蛋白(APP)，导致淀粉样肽有毒物质在脑内积聚或阿尔茨海默病相关等位基因APOE4的表达。在这些模型中，线粒体响应与淀粉样多肽或APOE4的毒性有关，而不是线粒体驱动发病机制。在这里，我们探索一种铜向线粒体输送机制中的遗传缺陷引发的线粒体新机制 (ATP7A，SLC31A1，COX17)，线粒体内膜柠檬酸转运蛋白SLC25A1和它的相互作用蛋白NDUFS3。后者是一种与阿尔茨海默病的遗传风险基因相关的基因.我们发现最终影响线粒体的这些基因突变下游的主要缺陷是胆固醇合成途径、胆固醇和载脂蛋白E的表达上调。这些发现有深刻的影响，因为他们认为胆固醇和载脂蛋白E的上调是阿尔茨海默氏症的关键风险因素疾病，是由影响线粒体的遗传缺陷引起的。我们的模型挑战了当前的规范认为线粒体功能障碍是导致突触功能障碍的一系列事件的末端环节阿尔茨海默氏症。我们设想我们的线粒体驱动的致病模型是一个强大的补充，而不是而不是取代目前由淀粉样肽或APOE4驱动的阿尔茨海默氏病的发病机制。我们认为线粒体作为病理的始发者是一个重要的概念，因为它认为疾病将在一个正前馈循环中解体，整合淀粉样多肽、APOE4、胆固醇和线粒体。我们将用老鼠突变体来验证这一假设，这些突变体会损害铜向线粒体的输送，并建立了具有临床和遗传学有效性的阿尔茨海默病动物模型。